• General
    Information
    • Welcome Message
    • Committee
    • Press & Media
    • Contact Us
  • Program
  • Advertising,
    Promotion & Exhibits
  • Registration
    Now Closed

  • Watch Session
    Recordings

    • Welcome Message
    • Committee
    • Contact Us
    • Press & Media
    • Registration
    • Promotion & Advertising
    • Program
    • Call for Abstracts
MENU
  • Home
  • Join Mailing List
  • IASLC.org
  • Contact Us
  • General
    Information
    • Welcome Message
    • Committee
    • Press & Media
    • Contact Us
  • Program
  • Advertising,
    Promotion & Exhibits
  • Registration
    Now Closed

  • Watch Session
    Recordings

  • Home
  • Join Mailing List
  • IASLC.org
  • Contact Us
  • #LiquidBiopsy20
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
Conquering Thoracic Cancers Worldwide
  • General
    Information
    • Welcome Message
    • Committee
    • Press & Media
    • Contact Us
  • Program
  • Advertising,
    Promotion & Exhibits
  • Registration
    Now Closed

  • Watch Session
    Recordings

Get Tickets!

PRESS & MEDIA

  • Press & Media

Tweets by IASLC

We welcome media to attend the IASLC 2020 Lung Cancer Hot Topic: Liquid Biopsy Virtual Meeting. Information including a link for registration and details about media policies and embargoes can be found below.

Registration and Media Requirements

Press and Media Registration Now Open
Register Now

Eligibility

  • Companies or organizations producing publications, videos and other products intended for marketing, advertising, financial analysis or public relations purposes may not register to attend the meeting as media.
  • Financial analysts; sales, advertising or marketing representatives; book publishers and book authors may not register as media but are welcome to register as regular attendees.
  • Public relations personnel and individuals from communications, print and online promotion services should register as a regular attendee (not as media).

Journalists, including photographers, must work exclusively for the outlet for which they are credentialed (exceptions for freelance journalists are detailed below). Journalists who use their media privileges to work for non-credentialed organizations will have their privileges revoked. Journalists are required to complete the media online pre-registration form and submit the following:

  • A letter of assignment on the letterhead of the news organization being represented.
  • A photocopy of official press credentials, such a press card issued by a recognized journalists’ association or a government-sanctioned press organization (IASLC does not recognize press cards issued by web-based organizations such as IFNM) and/or a business card issued by a recognized news organization.

Freelance journalists including photographers may work for multiple publications, as long as they confirm in advance that those publications are eligible for media registration. Freelance journalists must submit the following:

  • A letter of assignment on the letterhead of the news organization being represented.
  • A recent copy of the publication (a mailed copy, link to the publication’s website or a photocopy of a cover/issue published within the past 6 months).
Media Policies

Please read carefully as these policies have been updated for 2020, including:

  1. Press Release Policy
  2. Social Media Policy
  3. Presentation Slides and Poster Release Policy
  4. Media List Policy

Press Release Policy
Press releases that feature data or events involving the meeting should include the full name of the meeting, specifically: IASLC 2020 Lung Cancer Hot Topic: Liquid Biopsy Virtual Meeting hosted by the International Association for the Study of Lung Cancer. Further, we respectfully request that the release include the official conference hashtag: #LiquidBiopsy20. To learn more, please visit www.iaslc.org.

Social Media Policy
Organizations may use social media to disseminate news and information regarding abstracts being presented at the IASLC 2020 Lung Cancer Hot Topic: Liquid Biopsy Virtual Meeting. All information distributed through social media channels must adhere to the IASLC's embargo policy. Please use the IASLC's Liquid Biopsy hashtag, #LiquidBiopsy20 in any social media posts. Members of the media are permitted to transmit/share on any social media platform any presentation's slides without approval from the presenter and/or the IASLC unless explicitly forbidden. However, authors retain the copyright to their full slide presentations and all copyright laws apply to the reproduction, distribution and/or publication of slides. Representatives from academic institutions are permitted to share slides.

Presentation Slides and Poster Release Policy
Organizations may use social media to disseminate news and information regarding abstracts being presented at the IASLC 2020 Lung Cancer Hot Topic: Liquid Biopsy Virtual Meeting. Please use the IASLC's Liquid Biopsy hashtag, #LiquidBiopsy20 in any social media posts. Members of the media are permitted to transmit/share on any social media platform any presentation's slides without approval from the presenter and/or the IASLC unless explicitly forbidden. However, authors retain the copyright to their full slide presentations and all copyright laws apply to the reproduction, distribution and/or publication of slides. Representatives from academic institutions are permitted to share slides.

Media List Policy
The IASLC does not release media lists for the IASLC 2020 Lung Cancer Hot Topic: Liquid Biopsy Virtual Meeting.

For questions, please contact:

Chris Martin
VP Public Relations, David James Group
CMartin at DavidJamesGroup.com
Phone: +1 630 670 2745


Jan Mazotti
Associate Director, Marketing and Communications
Jan.Mazotti at iaslc.org



  • Stay Connected

    Keep up to date with Conference News & Alerts.
    Sign Up


     
    #LiquidBiopsy20
© 2020 International Association for the Study of Lung Cancer – IASLC LB 2020 | Privacy Notice

Conference Newsletter
Subscribe to the Newsletter to receive important information about the upcoming Conference.
Thank you! We look forward to connecting soon.
Click here to close this window
Whoops, looks like there was an issue with one of the fields above - please review above.
X